Clinical trial
Efficacy of Pea Hull Fiber Supplementation on Gastrointestinal Transit Time-induced Reduction in Proteolytic Fermentation and Enhancement of Wellness in Individuals With Lifestyle-related Chronic Disease and Overweight. (Phase 3)
NCT03354364 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Pea Hull Fiber Supplementation on Gastrointestinal Transit Time-induced Reduction in Proteolytic Fermentation and Enhancement of Wellness in Individuals With Lifestyle-related Chronic Disease and Overweight. (Phase 3)
- Lead sponsor
- University of Florida
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 11, 2017
- Completion date
- August 19, 2019
- Enrollment
- 23 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
kidney disease, chronic